Xiaoyuan Li

776 total citations
39 papers, 523 citations indexed

About

Xiaoyuan Li is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoyuan Li has authored 39 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoyuan Li's work include RNA modifications and cancer (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Genomics and Diagnostics (4 papers). Xiaoyuan Li is often cited by papers focused on RNA modifications and cancer (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cancer Genomics and Diagnostics (4 papers). Xiaoyuan Li collaborates with scholars based in China, United States and Switzerland. Xiaoyuan Li's co-authors include Chunmei Bai, Zhao Sun, Keyue Ding, Yongbo Zheng, Juan Meng, Dachun Zhao, Peng Zhou, Yafeng Liu, Claus Bachert and Gabriële Holtappels and has published in prestigious journals such as Oncogene, Scientific Reports and Journal of Allergy and Clinical Immunology.

In The Last Decade

Xiaoyuan Li

37 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyuan Li China 13 172 117 117 109 102 39 523
Lixin Fu China 11 226 1.3× 27 0.2× 174 1.5× 25 0.2× 33 0.3× 39 536
Tarig Osman Norway 11 165 1.0× 18 0.2× 60 0.5× 26 0.2× 28 0.3× 22 329
Jayendra B. Patel India 12 195 1.1× 100 0.9× 104 0.9× 106 1.0× 5 0.0× 24 448
Melisa W-Y. Ho United States 5 255 1.5× 6 0.1× 193 1.6× 45 0.4× 59 0.6× 10 586
Mingjing He China 16 443 2.6× 29 0.2× 194 1.7× 27 0.2× 7 0.1× 26 723
Gary Frenette United States 10 238 1.4× 266 2.3× 399 3.4× 21 0.2× 9 0.1× 16 723
Ivan Ngai United States 13 496 2.9× 31 0.3× 266 2.3× 8 0.1× 19 0.2× 22 819
Duygu Derin Türkiye 12 178 1.0× 10 0.1× 181 1.5× 14 0.1× 19 0.2× 24 424
Takahiro Wakasaki Japan 15 184 1.1× 168 1.4× 352 3.0× 8 0.1× 6 0.1× 51 599

Countries citing papers authored by Xiaoyuan Li

Since Specialization
Citations

This map shows the geographic impact of Xiaoyuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyuan Li more than expected).

Fields of papers citing papers by Xiaoyuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyuan Li. The network helps show where Xiaoyuan Li may publish in the future.

Co-authorship network of co-authors of Xiaoyuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyuan Li. A scholar is included among the top collaborators of Xiaoyuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyuan Li. Xiaoyuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaoyuan, Tiantian Guo, Lele Zhang, et al.. (2025). Fully automated volumetric assessment of tumor burden using artificial intelligence on 68Ga-PSMA-11 PET predicts survival after 177Lu-PSMA therapy in metastatic Castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 53(3). 1913–1926.
2.
Zhang, Li, Hui Wu, Xiaoyuan Li, et al.. (2025). Screening bioactive compounds from Qianghuo ( ) volatile oil via COX-2 magnetic ligand fishing. Fitoterapia. 182. 106432–106432. 1 indexed citations
4.
Xie, Wenhui, et al.. (2024). Cardiovascular and cerebrovascular outcomes in anti-neutrophil cytoplasmic antibody-associated vasculitis: A systematic review with meta-analysis. Autoimmunity Reviews. 23(6). 103587–103587. 1 indexed citations
5.
Liu, Yiran, et al.. (2024). Identification of a novel immunosenescence-related genes and integrative analyses in patients with psoriasis. Human Immunology. 86(1). 111218–111218. 2 indexed citations
6.
Dai, Ziyi, et al.. (2024). Anti-PD-1 immunotherapy for the treatment of metastatic urothelial carcinoma in a kidney transplant recipient: a case report. BMC Nephrology. 25(1). 390–390. 1 indexed citations
7.
Zhu, Wenjia, Xiaoyuan Li, Chunmei Bai, et al.. (2023). Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 50(10). 3116–3125. 20 indexed citations
8.
Tang, Xia, Lei Xiang, Qingshu Li, et al.. (2023). Molecular evolution in different subtypes of multifocal hepatocellular carcinoma. Hepatology International. 17(6). 1429–1443. 1 indexed citations
9.
Xie, Wenhui, et al.. (2023). Incidence, mortality, and risk factors of acute kidney injury after immune checkpoint inhibitors: Systematic review and meta-analysis of real-world evidence. European Journal of Internal Medicine. 115. 88–95. 12 indexed citations
10.
Li, Xiaoyuan, Hongwei Sun, Jianmin Yuan, et al.. (2022). Low-Dose 68 Ga-PSMA Prostate PET/MRI Imaging Using Deep Learning Based on MRI Priors. Frontiers in Oncology. 11. 818329–818329. 9 indexed citations
11.
Li, Xiaoyuan, et al.. (2021). Efficacy of Shenling Baizhu San on stable chronic obstructive pulmonary disease patients: A systematic review and meta-analysis. Journal of Ethnopharmacology. 272. 113927–113927. 11 indexed citations
12.
Li, Ningning, et al.. (2021). The Relationship Between Gut Microbiome Features and Chemotherapy Response in Gastrointestinal Cancer. Frontiers in Oncology. 11. 781697–781697. 37 indexed citations
13.
Wang, Yingyi, Na Zhou, Rui Zhu, et al.. (2021). Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression. BMC Pulmonary Medicine. 21(1). 282–282. 15 indexed citations
14.
Zhang, Guiji, Li Liang, Wanfeng Zhang, et al.. (2020). DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma. Oncogene. 39(16). 3229–3244. 31 indexed citations
15.
Li, Xiaoyuan, Zhikai Liu, Jie Li, et al.. (2020). Perceived quality of care and its associated factors among Chinese patients with advanced cancer: findings from the APPROACH study in Beijing. Supportive Care in Cancer. 29(3). 1395–1401. 4 indexed citations
16.
Chen, Fuquan, Qiao Li, Zhaohui Shi, et al.. (2019). Impact of Allergy and Eosinophils on the Morbidity of Chronic Rhinosinusitis with Nasal Polyps in Northwest China. International Archives of Allergy and Immunology. 179(3). 209–214. 12 indexed citations
17.
Shi, Zhaohui, Weihong Jiang, Min Wang, et al.. (2017). Inhibition of JAK/STAT pathway restrains TSLP-activated dendritic cells mediated inflammatory T helper type 2 cell response in allergic rhinitis. Molecular and Cellular Biochemistry. 430(1-2). 161–169. 41 indexed citations
18.
Zhao, Lin, Xiaoyuan Li, Chunmei Bai, & Shuchang Chen. (2008). [Post-operative adjuvant treatment with oxaliplatin, fluorouracil, and leucovorin for local advanced gastric cancer].. PubMed. 88(18). 1264–6. 1 indexed citations
19.
Li, Xiaoyuan. (2004). Effect of 532 nm Semi-conductor Laser Irradiation on Healing of the High-intensity Laser Wound in Rats. 1 indexed citations
20.
Li, Xiaoyuan, Ping Huang, Jingrong Jean Cui, Jennifer Zhang, & Cho Tang. (2003). Novel pyrrolyllactone and pyrrolyllactam indolinones as potent cyclin-Dependent kinase 2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(11). 1939–1942. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026